Cargando…

Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway

Cerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. In I/R injury, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) produces reactive oxygen species (ROS), which pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Sichao, Li, Fengwu, Wills, Melissa, Yip, James, Wehbe, Alexandra, Peng, Changya, Geng, Xiaokun, Ding, Yuchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307415/
https://www.ncbi.nlm.nih.gov/pubmed/35873710
http://dx.doi.org/10.1155/2022/6886752
_version_ 1784752758429057024
author Guo, Sichao
Li, Fengwu
Wills, Melissa
Yip, James
Wehbe, Alexandra
Peng, Changya
Geng, Xiaokun
Ding, Yuchuan
author_facet Guo, Sichao
Li, Fengwu
Wills, Melissa
Yip, James
Wehbe, Alexandra
Peng, Changya
Geng, Xiaokun
Ding, Yuchuan
author_sort Guo, Sichao
collection PubMed
description Cerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. In I/R injury, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) produces reactive oxygen species (ROS), which promote inflammatory and apoptotic pathways, augmenting ROS production and promoting cell death. Inhibiting ischemia-induced oxidative stress would be beneficial for reducing neuroinflammation and promoting neuronal cell survival. Studies have demonstrated that chlorpromazine and promethazine (C+P) induce neuroprotection. This study investigated how C+P minimizes oxidative stress triggered by ischemic injury. Adult male Sprague-Dawley rats were subject to middle cerebral artery occlusion (MCAO) and subsequent reperfusion. 8 mg/kg of C+P was injected into the rats when reperfusion was initiated. Neurologic damage was evaluated using infarct volumes, neurological deficit scoring, and TUNEL assays. NOX enzymatic activity, ROS production, protein expression of NOX subunits, manganese superoxide dismutase (MnSOD), and phosphorylation of PKC-δ were assessed. Neural SHSY5Y cells underwent oxygen-glucose deprivation (OGD) and subsequent reoxygenation and C+P treatment. We also evaluated ROS levels and NOX protein subunit expression, MnSOD, and p-PKC-δ/PKC-δ. Additionally, we measured PKC-δ membrane translocation and the level of interaction between NOX subunit (p47(phox)) and PKC-δ via coimmunoprecipitation. As hypothesized, treatment with C+P therapy decreased levels of neurologic damage. ROS production, NOX subunit expression, NOX activity, and p-PKC-δ/PKC-δ were all significantly decreased in subjects treated with C+P. C+P decreased membrane translocation of PKC-δ and lowered the level of interaction between p47(phox) and PKC-δ. This study suggests that C+P induces neuroprotective effects in ischemic stroke through inhibiting oxidative stress. Our findings also indicate that PKC-δ, NOX, and MnSOD are vital regulators of oxidative processes, suggesting that C+P may serve as an antioxidant.
format Online
Article
Text
id pubmed-9307415
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93074152022-07-23 Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway Guo, Sichao Li, Fengwu Wills, Melissa Yip, James Wehbe, Alexandra Peng, Changya Geng, Xiaokun Ding, Yuchuan Mediators Inflamm Research Article Cerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. In I/R injury, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) produces reactive oxygen species (ROS), which promote inflammatory and apoptotic pathways, augmenting ROS production and promoting cell death. Inhibiting ischemia-induced oxidative stress would be beneficial for reducing neuroinflammation and promoting neuronal cell survival. Studies have demonstrated that chlorpromazine and promethazine (C+P) induce neuroprotection. This study investigated how C+P minimizes oxidative stress triggered by ischemic injury. Adult male Sprague-Dawley rats were subject to middle cerebral artery occlusion (MCAO) and subsequent reperfusion. 8 mg/kg of C+P was injected into the rats when reperfusion was initiated. Neurologic damage was evaluated using infarct volumes, neurological deficit scoring, and TUNEL assays. NOX enzymatic activity, ROS production, protein expression of NOX subunits, manganese superoxide dismutase (MnSOD), and phosphorylation of PKC-δ were assessed. Neural SHSY5Y cells underwent oxygen-glucose deprivation (OGD) and subsequent reoxygenation and C+P treatment. We also evaluated ROS levels and NOX protein subunit expression, MnSOD, and p-PKC-δ/PKC-δ. Additionally, we measured PKC-δ membrane translocation and the level of interaction between NOX subunit (p47(phox)) and PKC-δ via coimmunoprecipitation. As hypothesized, treatment with C+P therapy decreased levels of neurologic damage. ROS production, NOX subunit expression, NOX activity, and p-PKC-δ/PKC-δ were all significantly decreased in subjects treated with C+P. C+P decreased membrane translocation of PKC-δ and lowered the level of interaction between p47(phox) and PKC-δ. This study suggests that C+P induces neuroprotective effects in ischemic stroke through inhibiting oxidative stress. Our findings also indicate that PKC-δ, NOX, and MnSOD are vital regulators of oxidative processes, suggesting that C+P may serve as an antioxidant. Hindawi 2022-07-15 /pmc/articles/PMC9307415/ /pubmed/35873710 http://dx.doi.org/10.1155/2022/6886752 Text en Copyright © 2022 Sichao Guo et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Guo, Sichao
Li, Fengwu
Wills, Melissa
Yip, James
Wehbe, Alexandra
Peng, Changya
Geng, Xiaokun
Ding, Yuchuan
Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title_full Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title_fullStr Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title_full_unstemmed Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title_short Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title_sort chlorpromazine and promethazine (c+p) reduce brain injury after ischemic stroke through the pkc-δ/nox/mnsod pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307415/
https://www.ncbi.nlm.nih.gov/pubmed/35873710
http://dx.doi.org/10.1155/2022/6886752
work_keys_str_mv AT guosichao chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT lifengwu chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT willsmelissa chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT yipjames chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT wehbealexandra chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT pengchangya chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT gengxiaokun chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT dingyuchuan chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway